Early detection of lysosomal storage disorders
CA 2253875 C · Owner: Hopwood, John J. · Inventors: Meikle, Peter J.; Brooks, Douglas A.; Hopwood, John J.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates generally to lysosomal storage disorders and to diagnostic agents for their detection in humans and other animals. More particularly, the present invention is directed to the uses of the LSD markers Lamp-1, Lamp-2, Limp-II 4-sulphatase, acid , phosphatase (ACP) .beta.-hexosaminidase or .alpha.-mannosidase amongst , others as diagnotic agents for the detection of many lysosomal storage disorders.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 16, 1997 and granted February 22, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended May 16, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 16, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.